AI assistant
Sending…
CVS HEALTH Corp — Director's Dealing 2009
May 14, 2009
29875_dirs_2009-05-14_d97da346-b62e-404f-98fc-78ce67ae2732.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS CAREMARK CORP (CVS)
CIK: 0000064803
Period of Report: 2009-05-12
Reporting Person: WILLIAMS KRISTEN GIBNEY (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2009-05-12 | Common Stock | M | 33726 | — | Acquired | 93437 | Direct |
| 2009-05-12 | Common Stock | M | 46856 | — | Acquired | 140293 | Direct |
| 2009-05-12 | Common Stock | M | 46849 | — | Acquired | 187142 | Direct |
| 2009-05-12 | Common Stock | S | 127431 | $32.8509 | Disposed | 59711 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2009-05-12 | Stock Option | $27.12 | M | 33726 | Disposed | 2016-03-01 | Common Stock (33726) | Direct |
| 2009-05-12 | Stock Option | $13.41 | M | 46856 | Disposed | 2014-01-02 | Common Stock (46856) | Direct |
| 2009-05-12 | Stock Option | $9.17 | M | 46849 | Disposed | 2013-02-25 | Common Stock (46849) | Direct |
Footnotes
F1: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $32.60 and $33.04 per share.
F2: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.
More from CVS HEALTH Corp
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Declaration of Voting Results & Voting Rights Announcements
2026
May 18
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3